Add like
Add dislike
Add to saved papers

Larvicidal activity prediction against Aedes aegypti mosquito using computational tools.

BACKGROUND & OBJECTIVES: Aedes aegypti is an important vector for transmission of dengue, yellow fever, chikun- gunya, arthritis, and Zika fever. According to the World Health Organization, it is estimated that Ae. aegypti causes 50 million infections and 25,000 deaths per year. Use of larvicidal agents is one of the recommendations of health organizations to control mosquito populations and limit their distribution. The aim of present study was to deduce a mathematical model to predict the larvicidal action of chemical compounds, based on their structure.

METHODS: A series of different compounds with experimental evidence of larvicidal activity were selected to develop a predictive model, using multiple linear regression and a genetic algorithm for the selection of variables, implemented in the QSARINS software. The model was assessed and validated using the OECDs principles.

RESULTS: The best model showed good value for the determination coefficient (R2 = 0.752), and others parameters were appropriate for fitting (s = 0.278 and RMSEtr = 0.261). The validation results confirmed that the model hasgood robustness (Q2LOO = 0.682) and stability (R2-Q2LOO = 0.070) with low correlation between the descriptors (KXX = 0.241), an excellent predictive power (R2 ext = 0.834) and was product of a non-random correlation R2 Y-scr = 0.100).

INTERPRETATION & CONCLUSION: The present model shows better parameters than the models reported earlier in the literature, using the same dataset, indicating that the proposed computational tools are more efficient in identifying novel larvicidal compounds against Ae. aegypti.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app